scholarly journals Immunosuppressive Properties of Infectious Bronchitis Vaccine4/91 strain against different programs and method of vaccination against Newcastle disease in Broilers

2012 ◽  
Vol 11 (3) ◽  
pp. 13
Author(s):  
A.H. Zahid
Keyword(s):  
Respiratory Disease ◽  
Infectious Bronchitis Virus ◽  
Newcastle Disease ◽  
Haemagglutination Inhibition ◽  
Challenge Test ◽  
Economic Losses ◽  
Control Group ◽  
Infectious Bronchitis ◽  
Spray Method ◽  
Significant Difference

Infectious bronchitis virus (IBV) primarily induces a respiratory disease in broilerscausing important economic losses in poultry industry. The aim of this study was to investigatethe immunosuppressive properties of live IB vaccine on the different programs and method ofvaccination against Newcastle disease (ND) in broilers. A total of 125 one-day-old broilerchicks were assigned into five equal groups. At day one G1 and G2groupswere vaccinated witha live (ND, IB)vaccine by dipping the head in the vaccine and intra-cloacae methodrespectively. Afterward, G3and G4 groups were vaccinated with a live ND vaccine alone by thesame method of G1 and G2. At the same time all these4 groups were vaccinated bysubcutaneous injection (S/C) with inactivated oil based vaccine ND. The G5 group was leftwithout vaccination as a control group. After that, all treated groups were vaccinated with a liveND by spray method at day 10 of the age. The immunosuppressive effects of this IB virus wasevaluated by Haemagglutination inhibition test (HI), and challenged by virulent ND virus.Bursa and Spleen indices were estimated in all groups. The results showed that the antibodytiters against ND was higher (P<0.05) in G3and G4 in compared with G1, G2 and controlgroups at 20 and 30 days of age. However, there was no significant difference of bursa indexand spleen index in all groups. Challenge test showed no mortality in the 3rd group while 10%in the 4th group, 85% in the 1st group and 90% in the 2nd group. In conclusion, it’s revealed thatthe best method and program of vaccination which can protect against ND was applied in the3rd group.

scholarly journals EFFECT OF VITAMIN E AND COD LIVER OIL SUPPLEMENT WITH BIVALENT OIL BASED VACCINE OF NEWCASTLE DISEASE AND INFECTIOUS BRONCHITIS DISEASE ON IMMUNE RESPONSE OF THE BROILERS.

2016 ◽  
Vol 47 (3) ◽  
Author(s):  
ABDULWAHID & et al.
Keyword(s):  
Immune Response ◽  
Vitamin E ◽  
Newcastle Disease ◽  
Challenge Test ◽  
Elisa Test ◽  
The Other ◽  
Control Group ◽  
Broiler Chicks ◽  
Cod Liver Oil ◽  
Infectious Bronchitis

This study was aimed to enhance the immune response of the broilers by vitamin E and Cod liver oil supplement with locally inactivated bivalent vaccine of Newcastle disease and Infectious bronchitis viruses. One hundred and twenty broiler chicks Ross 308 were divided to four groups at 30 chicks of each group. The 2nd group was vaccinated with 0.5ml/chick of locally inactivated ND-IB vaccine at 5 days old. The 3rd group was vaccinated with 0.5ml locally ND-IB vaccine and 0.1 ml/chick of VE. The 4th group was vaccinated with 0.5ml of locally ND-IB vaccine and 0.1ml/chick of Cod liver oil, while the first group was left without vaccination as a control group. All groups were vaccinated with attenuated ND-IB at 3 days old and attenuated IBD at 14 days old. The results of ELISA test revealed that the 3rd and 4th groups showed significantly increased (P≤0.05) in Ab titers against ND virus at aged 35 days, also, the 4th group showed significantly (P≤0.05) increased in Ab titers against IB virus at day 35 of age as compared with the other groups. The 4th group showed a significant (P≤0.05) increased in bursal index as compared with the other groups. The results of challenge test revealed that vaccinated groups resist the velogenic ND and IB viruses with relatively high productive range particularly the 4th group as compared with other groups. In conclusion, the VE and Cod liver oil supplement with local bivalent oil based vaccine of ND and IBV may enhance the immune response of the broilers particularly the 4th group which vaccinated with 0.5 ml of local bivalent oil based vaccine of ND-IB vaccine and 0.1 ml Cod liver oil.

scholarly journals Influence of Maternal Antibody on the Efficacy of Newcastle Disease Vaccination in Broilers

2020 ◽  
pp. 108-114
Author(s):  
Pubaleem Deka ◽  
Sangeeta Das ◽  
Pankaj Deka
Keyword(s):  
Newcastle Disease ◽  
Half Life ◽  
Haemagglutination Inhibition ◽  
Maternal Antibody ◽  
Control Group ◽  
Broiler Chicks ◽  
Economic Implication ◽  
Group I ◽  
Significant Difference ◽  
Unvaccinated Control

The half-life of maternal antibody (mAb) titres against Newcastle Disease Virus (NDV) were estimated in order to trace its likely declining pattern and the influence on the efficacy of vaccination in broiler chicks. Our study was also conducted to compare two vaccination regimens with live and inactivated NDV vaccine. For this purpose, ninety day-old broiler chicks with known NDV vaccination history of parent stock were randomly allocated into three groups (I) unvaccinated control, (II) Live NDV vaccine, and (III) Live + Inactivated NDV vaccine. Haemagglutination-inhibition (HI) antibodies were determined in the pre- and post-vaccination sera of the experimental chicks. The results indicated that the unvaccinated group showed higher level of mAb against NDV at day 1 with HI antibody titre (Log2) 9.32 which was maintained up to 7 days of age (8.11) and gradually declined with no measurable antibodies of maternal origin after day 14, signifying the initiation of Newcastle Disease (ND) vaccination at 7 days of age. The vaccinated Group II and III revealed significantly higher HI titre at day 14 (11.52, 12.42), day 21 (12.95, 13.22), day 28 (11.63, 12.18) and day 35 (13.31, 13.39) than the unvaccinated control group I. Moreover, there is no significant difference in humoral immune response among both the vaccinated groups. Thus, our study suggests the use of live NDV vaccines for ND prevention in commercial broiler farming over the inactivated NDV vaccines which demands a withdrawal period before slaughter and its economic implication due to additional cost. This study also indicated that the half-life values of mAb and its effect should be considered while customizing an effective vaccine regimen.

scholarly journals Evaluation of Cross Protective Efficacy of Commercial Vaccines against Mannheimia haemolytica in Mice

2019 ◽  
Vol 43 (1) ◽  
pp. 165-170
Author(s):  
Waffa A. Ahmed
Keyword(s):  
Immunosorbent Assay ◽  
Protective Efficacy ◽  
Challenge Test ◽  
Cross Protection ◽  
Mannheimia Haemolytica ◽  
Economic Losses ◽  
Enzyme Linked Immunosorbent Assay ◽  
Control Group ◽  
Significant Difference ◽  
Protection Efficacy

Mannheimia haemolytica together with Pasteurella multocida represents as a major bacterial causative agent of cattle, sheep and goats respiratory diseases and its one of the most important causes for economic losses to these animals .Commercially available vaccines were used to prevent infections caused by P. multocida and M. haemolytica. Thus, the aim of the present study was to evaluate the cross protection efficacy of two vaccines to protect mice against M.haemolytica, studying humeral immunity, using Enzyme-Linked Immunosorbent Assay. Forty five mice were divided into three equal groups, group one and two were inoculated subcutaneously  4μl\JOVAPAST® and 1μl of Al-kindy vaccines respectively, while the third group was with 0.5 ml sub cutaneous PBS. LD50for M.haemolytica was estimated as 2× 106 cfu \ml and challenge test was conducted by dropping 0.05 ml 2× 106 cfu \ml intranasally after three weeks of immunization for the three groups. The results of Enzyme-Linked Immunosorbent Assay, showed significant increase of antibody titters at (P<0.01) in (group 1 and 2) after first and second weeks post immunization, in comparison with control group. Also, the re-isolation of M.haemolytica from lungs tissue of all groups after challenged were positive with significant difference between control and immunized group, control group was 4× 108 cfu ∕ml which was higher than immunized group one and group two,which were 2.5×104 cfu∕ml and 3,5×105 cfu∕ml respectively after 24 hour of vaccine. In conclusion, the two commercial vaccines showed good cross protection efficacy against M. haemolytica, but JOVAPAST® vaccine showed higher efficacy than Alkindy vaccine, as that it contain  two  heterologous  killed strains and providing the basis for production a vaccine from the two  pathogen of local strains. 

scholarly journals Effect of infectious bronchitis and Newcastle disease vaccines on experimental avian influenza infection (H9N2) in broiler chickens

2021 ◽  
Vol 24 (4) ◽  
pp. 574-585
Author(s):  
R. Amanollahi ◽  
K. Asasi ◽  
B. Abdi-Hachesoo ◽  
N. Ahmadi ◽  
A. Mohammadi
Keyword(s):  
Avian Influenza ◽  
Newcastle Disease ◽  
Broiler Chickens ◽  
Clinical Signs ◽  
Respiratory Pathogen ◽  
Economic Losses ◽  
Control Group ◽  
Virus Shedding ◽  
Live Vaccines ◽  
Infectious Bronchitis

Despite the fact that H9N2 avian influenza virus (AIV) is considered a low-pathogenic agent, frequent outbreaks of this subtype have caused high mortality and economic losses in poultry farms around the world including Iran. Coinfection with a respiratory pathogen or environmental factors may explain the exacerbation of H9N2 AIV infection. In this study, the role of infectious bronchitis (IB) vaccines (H120 and 4/91) and Newcastle disease (ND) vaccines (B1 and LaSota) on experimental H9N2 AIV infection was investigated in 180 broiler chickens allotted into 6 groups (n=30). At the age of 18 days, groups 3 and 4 received H120 and 4/91 infectious bronchitis live vaccines (IBLVs) and groups 5 and 6 received B1 and LaSota Newcastle disease live vaccines (NDLVs), respectively. At the age of 20 days, all birds in the experimental groups except the negative control group (group 1), were inoculated intra-nasally with H9N2 AIV. After the inoculation, clinical signs, gross and microscopic lesions, and viral detection were examined. The results of this study revealed that clinical signs, gross and microscopic lesions were more severe in the AIV challenged groups which had been previously vaccinated with IB vaccines. In addition, AI viral RNA from tracheal and faecal samples in IB vaccinated birds were recovered at a higher rate. Moreover, in the 4/91 IB vaccinated group, the AI virus shedding period was longer than the other challenged groups. In conclusion, infectious bronchitis live vaccines (IBLVs) exacerbated the H9N2 AIV infection; also, 4/91 IBLV extended AI virus shedding period and increased the recovery rate of AI virus from feaces. However, the coinfection of Newcastle disease live vaccines (NDLVs) had no considerable adverse effects on AIV infection in broiler chickens.

scholarly journals Near-Complete Genome Sequence of GI-17 Lineage Infectious Bronchitis Virus, Circulating in Iowa

2021 ◽  
Vol 10 (20) ◽  
Author(s):  
Amro Hashish ◽  
Yuko Sato ◽  
Ganwu Li ◽  
Ying Zheng ◽  
Phillip C. Gauger ◽  
...  
Keyword(s):  
Respiratory Disease ◽  
Genome Sequence ◽  
Causative Agent ◽  
Infectious Bronchitis Virus ◽  
Complete Genome Sequence ◽  
Complete Genome ◽  
Economic Losses ◽  
Avian Infectious Bronchitis Virus ◽  
Poultry Industry ◽  
Infectious Bronchitis

ABSTRACT Avian infectious bronchitis virus (AvIBV) is the causative agent of a highly contagious respiratory disease in chickens which results in significant economic losses in the poultry industry. Here, we report a near-complete genome sequence of the strain, designated IA1162/2020, identified in tracheal swabs from chickens in Iowa in 2020.

scholarly journals Seroprevalence and Associated Risk Factors of Infectious Bronchitis Virus in Chicken in Northwest Ethiopia

2021 ◽  
Vol 2021 ◽  
pp. 1-10
Author(s):  
M. Birhan ◽  
M. Temesgen ◽  
A. Shite ◽  
N. Berhane ◽  
M. Bitew ◽  
...  
Keyword(s):  
Risk Factors ◽  
Potential Risk ◽  
Infectious Bronchitis Virus ◽  
Northwest Ethiopia ◽  
Economic Losses ◽  
Mixed Effect ◽  
Infectious Bronchitis ◽  
Farm Type ◽  
Significant Difference ◽  
Potential Risk Factors

Avian infectious bronchitis virus is a highly contagious disease occurring in respiratory, urogenital, and reproductive tissues of chicken causing considerable losses due to death, egg drop, and reduced production. This preliminary study was conducted to investigate the prevalence of antibodies against infectious bronchitis virus (IBV) and to assess the potential risk factors in chickens of northwest Ethiopia. A cross-sectional study was conducted from November 2020 to June 2021. A total of 768 serum samples from three zones were collected. To investigate the presence of antibodies against IBV, the indirect ELISA serological test was applied. Positivity for anti-IBV antibodies was observed in 23.96% (95% CI: 20.98–27.14) of the samples. The mixed-effect logistic regression analysis of potential risk factors showed that IBV prevalence was significantly higher in young chickens than adults ( p < 0.001 ) and higher in intensive farm type than in extensive type ( p < 0.001 ). Based on the production purposes of the chickens, the odds of seropositivity for IB was significantly higher in layers than in broilers ( p < 0.001 ) and dual purposes ( p < 0.001 ). This study revealed higher seroprevalence in farms which had the “all-in-all-out” rearing method than in farms with different batches in one house with a significant difference ( p < 0.001 ), higher seroprevalence in the poor ventilated type than in good ones ( p < 0.001 ), and higher seroprevalence in the houses that did not remove used litter at all than houses of completely disposed and partially disposed litter ( p = 0.002 ). Moreover, disinfection of houses had significant effect on the occurrence of IB. Having personal protective equipment was significantly affecting the occurrence of IB, being higher in the farms that have no wearing clothes and shoe than in those having wearing clothes and shoe ( p = 0.002 ). In conclusion, the seroprevalence finding in the present study indicated that the organism is circulating among the population of chickens and high enough to cause significant economic losses Therefore, poultry houses should be cleaned, disinfected, and well ventilated and farm attendants should have separate farm shoe and clothes. Further studies on the virus isolation and molecular characterization of the target gene are needed in the study area.

scholarly journals Nephropathogenic Infectious Bronchitis Virus Infection Altered the Metabolome Profile and Immune Function of the Bursa of Fabricius in Chicken

2021 ◽  
Vol 7 ◽  
Author(s):  
Jun Kuang ◽  
Puzhi Xu ◽  
Yan Shi ◽  
Yitian Yang ◽  
Ping Liu ◽  
...  
Keyword(s):  
Immune Function ◽  
Inflammatory Cytokines ◽  
Infectious Bronchitis Virus ◽  
Metabolic Profile ◽  
Bursa Of Fabricius ◽  
Economic Losses ◽  
Control Group ◽  
Phenyllactic Acid ◽  
Infectious Bronchitis ◽  
Infectious Bronchitis Virus Infection

Infectious bronchitis is a highly contagious, acute viral respiratory disease of chickens, regardless of the strain, and its infection may lead to considerable economic losses to the poultry industry. New nephropathogenic infectious bronchitis virus (NIBV) strains have increasingly emerged in recent years; hence, evaluating their infection-influenced immune function changes and the alteration of metabolite profiling is important. Initially, chickens were randomly distributed into two groups: the control group (Con) and the disease group (Dis). Here, the partial cytokines were examined, and the metabolome alterations of the bursa of Fabricius (BF) in NIBV infections in chickens were profiled by gas chromatography time-of-flight/mass spectrometry (GC-TOF/MS). The results revealed that the NIBV infection promotes the mRNA expression of inflammatory cytokines. Metabolic profile analysis indicated that clustering differed between the two groups and there were 75 significantly different metabolites detected between the two groups, suggesting that the host metabolism was significantly changed by NIBV infection. Notably, the following 12 metabolites were identified as the potential biomarkers: 3-phenyllactic acid, 2-deoxytetronic acid, aminomalonic acid, malonamide 5, uric acid, arachidonic acid, 2-methylglutaric acid, linoleic acid, ethanolamine, stearic acid, N-alpha-acetyl-l-ornithine, and O-acetylserine. Furthermore, the results of the correlation analysis showed that a strong correlation existed between metabolic biomarkers and inflammatory cytokines. Our results describe an immune and metabolic profile for the BF of chickens when infected with NIBV and provide new biomarkers of NIBV infection as potential targets and indicators of indicating therapeutic efficacy.

scholarly journals Design and Characterization of a DNA Vaccine Based on Spike with Consensus Nucleotide Sequence against Infectious Bronchitis Virus

Vaccines ◽  
2021 ◽  
Vol 9 (1) ◽  
pp. 50
Author(s):  
Lei Zuo ◽  
Wenjun Yan ◽  
Zhou Song ◽  
Hao Li ◽  
Xin Xie ◽  
...  
Keyword(s):  
Nucleotide Sequence ◽  
Dna Vaccine ◽  
Infectious Bronchitis Virus ◽  
Neutralizing Antibody ◽  
Economic Losses ◽  
Post Translational Modification ◽  
Virus Shedding ◽  
Infectious Bronchitis ◽  
Specific Pathogen ◽  
Cellular Immune

Avian coronavirus infectious bronchitis virus (IBV) causes severe economic losses in the poultry industry, but its control is hampered by the continuous emergence of new genotypes and the lack of cross-protection among different IBV genotypes. We designed a new immunogen based on a spike with the consensus nucleotide sequence (S_con) that may overcome the extraordinary genetic diversity of IBV. S_con was cloned into a pVAX1 vector to form a new IBV DNA vaccine, pV-S_con. pV-S_con could be correctly expressed in HD11 cells with corresponding post-translational modification, and induced a neutralizing antibody response to the Vero-cell-adapted IBV strain Beaudette (p65) in mice. To further evaluate its immunogenicity, specific-pathogen-free (SPF) chickens were immunized with the pV-S_con plasmid and compared with the control pVAX1 vector and the H120 vaccine. Detection of IBV-specific antibodies and cell cytokines (IL-4 and IFN-γ) indicated that vaccination with pV-S_con efficiently induced both humoral and cellular immune responses. After challenge with the heterologous strain M41, virus shedding and virus loading in tissues was significantly reduced both by pV-S_con and its homologous vaccine H120. Thus, pV-S_con is a promising vaccine candidate for IBV, and the consensus approach is an appealing method for vaccine design in viruses with high variability.

scholarly journals Cocirculation of Four Infectious Bronchitis Virus Lineages in Broiler Chickens in the Eastern Region of Saudi Arabia from 2012 to 2014

2020 ◽  
Vol 2020 ◽  
pp. 1-10 ◽  
Author(s):  
Abdullah I. A. Al-Mubarak ◽  
Anwar A. G. Al-Kubati
Keyword(s):  
Saudi Arabia ◽  
Middle East ◽  
Infectious Bronchitis Virus ◽  
Broiler Chickens ◽  
Direct Sequencing ◽  
Hypervariable Region ◽  
Economic Losses ◽  
Eastern Region ◽  
Infectious Bronchitis ◽  
First Time

Avian infectious bronchitis virus (IBV) is an evolving and dynamic virus that causes major economic losses for the poultry industry worldwide. Continuous evolution and emergence of new variants of this virus are the major challenges for controlling the disease with routine vaccination. Successful vaccination usually requires the use of a homologous vaccine, which in turn necessitates continuous investigation of the circulating strains. Herein, we performed a reverse transcriptase-polymerase chain reaction- (RT-PCR-) based investigation in broiler chicken flocks of the Eastern Region of Saudi Arabia. IBV was detected in 36.5% of the tested flocks (42 out of 115) from January 2012 to March 2014. Direct sequencing of hypervariable region-3 (HVR-3) of the Spike (S)-1 gene was performed, followed by phylogenetic analysis to determine the circulating IBV genotypes. Four lineages appear to coexist in this region, including the GI-13 or 4/91 IBV (31%), GI-16 or CK/CH/LDL/97I IBV (28.6%), GI-1 or Mass IBV (19%), and GI-23 or Middle East IBV (21.4%). The latter lineage include two subgroups: IS/720/99 IBV (16.7%) and IS/Variant2/98 IBV (4.7%). Some of the detections made in the 4/91 and Mass lineages are expected to belong to the vaccine strains. Lineages without a homologous vaccine in use (CK/CH/LDL/97I and Middle East) represent 50% of the isolates recovered in this study. Based on identity with the vaccine sequences, field observations, and frequent detection, these two lineages appear to be out of coverage of the IBV vaccines used in Saudi Arabia. This is the first time to identify Middle East lineage (IS/720/99 IBV and IS/Variant2/98 IBV) in the Eastern Region of Saudi Arabia.

Sign in / Sign up

Export Citation Format

Share Document